News

Why is there so little e-prescribing in Canada? New whitepaper explores the benefits
‘The continued reliance on outdated, paper- and fax-based prescribing systems introduces significant risks, contributing to medication errors, privacy breaches and administrative burdens that compromise patient care and place undue strain on clinicians,’ the study's authors write.
Proposal to explore emergency service line for Winnipeg mental health calls approved
The city’s executive policy committee approved Tuesday a motion from Mayor Scott Gillingham for his office to work with a consulting firm to outline how a proposed Winnipeg Community Response Service could work with community partners, health-system supports and the city’s 911 operations.

How a rare drug made from scientists' blood saves babies from botulism

Licensed in 2003, BabyBIG is the brand name for human botulism immune globulin, an IV medication that uses antibodies from volunteers vaccinated against botulism to help babies too young to fight the disease on their own.
Manitoba is the first province to collect data on patients' race—so what has it learned?

Dr. Marcia Anderson spearheaded the project to begin voluntary collection of this data across the province.
December drug news roundup: Five new products pharmacists and physicians should know about

Get the info you need on these new products, part of our drug news roundup for December.
Expanding psychologists’ scope of practice would undermine continuity of care: CFPC

The College of Family Physicians of Canada is urging the Ontario government to reconsider its plan to expand the scopes of practice for psychologists and other health professionals.
Physicians and NPs can’t issue broad authorizations to let RNs inject Botox, Sask. doctors’, nurses’ colleges warn

The two colleges say they’ve been contacted by Health Canada over reports that some physicians and NPs are issuing broad directives to authorize RNs to administer injections of bioactive agents, in contravention of the Food and Drugs Act.
B.C. to raise PharmaCare dispensing fees while limiting daily dispenses per patient

The province says this move is aimed at disincentivizing pharmacies from offering cash incentives to patients.
Health Canada approves first pill to treat postpartum depression

Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.
Tell us your story: Is your team redefining collaborative care?

Let us know about teams anchored by physicians but heavily integrated with NPs and PAs that are innovative and working well.

Why is there so little e-prescribing in Canada? New whitepaper explores the benefits

Proposal to explore emergency service line for Winnipeg mental health calls approved

How a rare drug made from scientists' blood saves babies from botulism

Manitoba is the first province to collect data on patients' race—so what has it learned?

December drug news roundup: Five new products pharmacists and physicians should know about

Expanding psychologists’ scope of practice would undermine continuity of care: CFPC

Physicians and NPs can’t issue broad authorizations to let RNs inject Botox, Sask. doctors’, nurses’ colleges warn

B.C. to raise PharmaCare dispensing fees while limiting daily dispenses per patient

Health Canada approves first pill to treat postpartum depression

Tell us your story: Is your team redefining collaborative care?

Related Topics